Paper I
2013 April (2010 Scheme) · 40 marks · 180 min
Question
Low molecular weight heparins
Q171 marksShort Answers
Related Concepts
Other Years Asked
- 1A 52-year-old man presented with complaints of tightness and discomfort in middle part of chest, particularly after brisk walking. This is relived within 10 minutes of rest. A diagnosis of Angina pectoris was made by physician after appropriate investigations. (2023 July (Supplementary) (2019 Scheme)Essay · 15 marks
- 2(2022 February (2019 Scheme)Short Essay · 8 marks
- 3(2022 July (Supplementary) (2019 Scheme)Short Essay · 8 marks
- 4Discuss the management of drug induced Parkinsonism. Discuss the management of megaloblastic anaemia. (4+4)2024 June (Supplementary) (2019 Scheme)Short Essay · 8 marks
- 5Heparin. (2+3+3)2023 January (Supplementary) (2019 Scheme)Short Essay · 8 marks
- 6Mention two low molecular weight heparins. Explain their mechanism of action. What are the differences between unfractionated heparin and low molecular weight heparins. (1+2+3)2024 December (Supplementary) (2019 Scheme)Short Essay · 6 marks
- 7Read the clinical problem and answer the following question: Mr.Shankar, 54 years suddenly developed severe chest pain. He was a diabetic and admitted in the ICCU with the diagnosis of acute myocardial infarction,2015 February (2010 Scheme)Essay · 6 marks
- 8A 24year old lady comes to the OPD with complaints of high fever with chills and rigors for the past 3 days. She also complains of headache, body ache and weakness. The fever lasts for 4 to 6 hours and subsides after sweating. You make a diagnosis of malaria based on blood smear which showed P. vivax parasites.2024 August (Supplementary) (2010 Scheme)Essay · 6 marks
- 9Pharmacological basis for the use of Protamine sulphate in heparin overdosage.2024 June (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 10(2022 July (Supplementary) (2019 Scheme)Short Essay · 4 marks
- 11Mechanism of action and therapeutic indications of Atorvastatin2024 March (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 12Explain the rationale of Levodopa and Carbidopa fixed drug combination in Parkinson’s disease2025 March (Supplementary (SAY)) (2019 Scheme)Short Answer · 4 marks
- 13Streptokinase.2023 July (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 14Pharmacological basis for the use of Fenofibrate in Hyperlipedemia.2023 July (Supplementary) (2019 Scheme)Short Answer · 4 marks
- 15Clopidogrel.2017 August (Supplementary) (2010 Scheme)Short Note · 3 marks
- 16Low molecular weight heparins2021 May (Supplementary) (2010 Scheme)Short Note · 3 marks
- 17Fibrinolytic drugs2019 July (Supplementary) (2010 Scheme)Short Note · 3 marks
- 18Heparin2024 March (Supplementary) (2010 Scheme)Short Note · 3 marks
- 19Low molecular weight heparin2017 February (2010 Scheme)Short Note · 3 marks
- 20Atorvastatin2024 August (Supplementary) (2010 Scheme)Short Note · 3 marks
- 21Low dose Aspirin.2025 August (Supplementary) (2010 Scheme)Short Note · 3 marks
- 22Clopidogrel2018 February (2010 Scheme)Short Note · 3 marks
- 23Second generation antihistaminic agents2021 May (Supplementary) (2010 Scheme)Short Note · 3 marks
- 24Ezetimibe2023 July (Supplementary) (2010 Scheme)Short Note · 3 marks
- 25Heparin.2015 February (2010 Scheme)Short Note · 3 marks
- 26Treatment of Iron deficiency anemia2017 August (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 27Beta blockers in angina2021 May (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 28Heparin overdosage is treated with:2024 December (Supplementary) (2019 Scheme)MCQ · 1 mark
- 29Radical cure in plasmodium vivax infection2014 March (2010 Scheme)Short Answer · 1 mark
- 30Combination of adrenaline with lignocaine in infiltration local anesthesia2019 July (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 31Carbidopa in combination with Levodopa.2021 December (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 32Two differences between heparin and warfarin2014 March (2010 Scheme)Short Answer · 1 mark
- 33Fibrinolytic agents2018 February (2010 Scheme)Short Answer · 1 mark
- 34Dextran2022 May (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 35Atorvastatin in primary hyperlipidaemia.2025 August (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 36Levodopa and carbidopa in parkinsonism2023 July (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 37Aspirin in the secondary prevention of Ischaemic heart disease2024 August (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 38Thrombolytic agents2017 February (2010 Scheme)Short Answer · 1 mark
- 39Levodopa and Carbidopa in the treatment of Parkinsonism2024 March (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 40Low dose Aspirin in prophylaxis of myocardial infarction2023 March (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 41Rationale for use of prostaglandin in acid peptic disease2015 September (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 42Acute myocardial infarction.2016 October (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 43The direct oral anticoagulants (DOACs) that inhibit factor Xa are2025 March (Supplementary (SAY)) (2019 Scheme)MCQ (Multi) · 1 mark
- 44Anti platelet drugs2013 April (2010 Scheme)Short Answer · 1 mark
- 45Low molecular weight heparins2015 September (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 46Iron deficiency anemia.2016 October (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 47Hyperlipidemia2014 March (2010 Scheme)Short Answer · 1 mark
- 48Assertion (A): Aspirin is used for its antiplatelet effects to prevent blood clots. Reason (R): Aspirin inhibits the enzyme cyclooxygenase (COX), which decreases thromboxane A2 production, a molecule that promotes platelet aggregation.2025 March (Supplementary (SAY)) (2019 Scheme)MCQ (A/R) · 1 mark
- 49Adrenaline with lignocaine in local anaesthesia2022 October (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 50Vitamin K in warfarin toxicity2022 May (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 51Fibrinolytics.2016 February (2010 Scheme)Short Answer · 1 mark
- 52Levodopa and carbidopa combination in Parkinson’s disease2019 July (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 53Hyperlipidemia.2016 February (2010 Scheme)Short Answer · 1 mark
- 54Due to her intolerance, the physician decides to initiate parenteral iron therapy to restore her iron levels effectively. The following iron preparation may be used in her by intravenous route:2024 December (Supplementary) (2019 Scheme)MCQ · 1 mark
- 55Adrenaline with lignocaine for tooth extraction2023 July (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 56Human erythropoietin (Epoietin)2020 February (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 57Tenecteplase2019 February (2010 Scheme)Short Answer · 1 mark
- 58Low molecular weight heparin2023 March (Supplementary) (2010 Scheme)Short Answer · 1 mark
- 59Plasma expanders2019 July (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 60Plasma expanders2023 July (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 61HMG CoA reductase inhibitors2025 March (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 62Low molecular weight heparin2020 February (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 63Second generation antihistaminics2022 October (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 64Antiplatelet agent2019 February (2010 Scheme)Short Answer · 0.3 marks
- 65Antiplatelet drugs2021 May (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 66Oral direct factor Xa inhibitors2021 February (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 67Fibrates2022 May (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 68Metoclopramide as antiemetic in paediatric population Name the following (Two examples for each) (5x1=5)2023 July (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 69Atropine as a Pre anaesthetic medication Name the following (Two examples for each): (5x1=5)2024 August (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 70Parenteral preparations of Iron2023 March (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 71Fibrinolytics2024 August (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 72Plasma expanders2024 August (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 73Warfarin as Anticoagulant in pregnancy.2025 March (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 74Fibrinolytic drugs.2025 August (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 75Recombinant tissue plasminogen activators2021 February (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 76Hypolipidaemic drugs2024 March (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 77Second generation antihistaminics.2025 August (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 78Fibrinolytics2023 July (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 79HMG-CoA Reductase inhibitors2022 October (Supplementary) (2010 Scheme)Short Answer · 0.3 marks
- 80 Levocetirizine for a machine operator. Name the following (Two examples for each): (8x1=8)2024 June (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 81Chlorpheniramine maleate for Acute Rhinitis in a driver2022 July (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 82Parenteral iron preparation.2024 June (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 83Centrally acting alpha-2 receptor agonists.2023 January (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 84Fibrinolytic drugs.2022 July (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 85Antiplatelet agents2022 February (2019 Scheme)Short Answer · 0.2 marks
- 86Drugs used to treat Venous thromboembolism2024 March (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 87 Domperidone for vomiting in a Parkinsonism patient on Levo Dopa. Name the following (Two examples for each) : (8x1=8)2023 July (Supplementary) (2019 Scheme)Short Answer · 0.2 marks
- 88Drugs for treating Malaria.2023 July (Supplementary) (2019 Scheme)Short Answer · 0.2 marks

